Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing.

Kong LY, Eyre DW, Corbeil J, Raymond F, Walker AS, Wilcox MH, Crook DW, Michaud S, Toye B, Frost E, Dendukuri N, Schiller I, Bourgault AM, Dascal A, Oughton M, Longtin Y, Poirier L, Brassard P, Turgeon N, Gilca R, Loo VG.

Clin Infect Dis. 2019 Jan 7;68(2):204-209. doi: 10.1093/cid/ciy457.

2.

Detection and Isolation of Clostridium difficile Asymptomatic Carriers During Clostridium difficile Infection Outbreaks: An Exploratory Study.

Paquet-Bolduc B, Gervais P, Roussy JF, Trottier S, Oughton M, Brukner I, Longtin J, Loo VG, Dascal A, Longtin Y.

Clin Infect Dis. 2018 Nov 13;67(11):1781-1783. doi: 10.1093/cid/ciy425.

PMID:
29771298
3.

Understanding Clostridium difficile Colonization.

Crobach MJT, Vernon JJ, Loo VG, Kong LY, Péchiné S, Wilcox MH, Kuijper EJ.

Clin Microbiol Rev. 2018 Mar 14;31(2). pii: e00021-17. doi: 10.1128/CMR.00021-17. Print 2018 Apr. Review.

4.

Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.

Semret M, Schiller I, Jardin BA, Frenette C, Loo VG, Papenburg J, McNeil SA, Dendukuri N.

J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.

5.

Impact of Isolating Clostridium difficile Carriers on the Burden of Isolation Precautions: A Time Series Analysis.

Xiao Y, Paquet-Bolduc B, Garenc C, Gervais P, Trottier S, Roussy JF, Longtin J, Loo VG, Longtin Y.

Clin Infect Dis. 2018 Apr 17;66(9):1377-1382. doi: 10.1093/cid/cix1024.

PMID:
29149279
6.

Household Transmission of Clostridium difficile to Family Members and Domestic Pets.

Loo VG, Brassard P, Miller MA.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1342-1348.

PMID:
27767004
7.

Effect Of Detecting and Isolating Asymptomatic Clostridium difficile Carriers-Reply.

Longtin Y, Gilca R, Loo VG.

JAMA Intern Med. 2016 Oct 1;176(10):1573. doi: 10.1001/jamainternmed.2016.5342. No abstract available.

PMID:
27695841
8.

Predictive computational phenotyping and biomarker discovery using reference-free genome comparisons.

Drouin A, Giguère S, Déraspe M, Marchand M, Tyers M, Loo VG, Bourgault AM, Laviolette F, Corbeil J.

BMC Genomics. 2016 Sep 26;17(1):754.

9.

A Cluster of Three Cases of Hantavirus Pulmonary Syndrome among Canadian Military Personnel.

Parkes LO, Nguyen TT, Longtin J, Beaudoin MC, Bestman-Smith J, Vinh DC, Boivin G, Loo VG.

Can J Infect Dis Med Microbiol. 2016;2016:2757969. doi: 10.1155/2016/2757969. Epub 2016 Apr 10.

10.

Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, Trottier S, Gervais P, Roussy JF, Lévesque S, Ben-David D, Cloutier I, Loo VG.

JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177.

PMID:
27111806
11.

Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance.

Kong LY, Jean A, Wong H, Semret M, Frenette C, Simor AE, Fenn S, Loo VG.

Diagn Microbiol Infect Dis. 2015 Dec;83(4):377-8. doi: 10.1016/j.diagmicrobio.2015.09.001. Epub 2015 Sep 4. No abstract available.

PMID:
26422086
12.

Excretion of Host DNA in Feces Is Associated with Risk of Clostridium difficile Infection.

Vincent C, Mehrotra S, Loo VG, Dewar K, Manges AR.

J Immunol Res. 2015;2015:246203. doi: 10.1155/2015/246203. Epub 2015 May 18.

13.

Predictors of asymptomatic Clostridium difficile colonization on hospital admission.

Kong LY, Dendukuri N, Schiller I, Bourgault AM, Brassard P, Poirier L, Lamothe F, Béliveau C, Michaud S, Turgeon N, Toye B, Frost EH, Gilca R, Dascal A, Loo VG.

Am J Infect Control. 2015 Mar 1;43(3):248-53. doi: 10.1016/j.ajic.2014.11.024.

PMID:
25728150
14.

Environmental interventions to control Clostridium difficile.

Loo VG.

Infect Dis Clin North Am. 2015 Mar;29(1):83-91. doi: 10.1016/j.idc.2014.11.006. Epub 2015 Jan 5. Review.

PMID:
25573675
15.

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update.

Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN.

Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S48-65. No abstract available.

PMID:
25376069
16.

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.

Dubberke ER, Carling P, Carrico R, Donskey CJ, Loo VG, McDonald LC, Maragakis LL, Sandora TJ, Weber DJ, Yokoe DS, Gerding DN.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):628-45. doi: 10.1086/676023. No abstract available.

PMID:
24799639
17.

Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection.

Vincent C, Stephens DA, Loo VG, Edens TJ, Behr MA, Dewar K, Manges AR.

Microbiome. 2013 Jun 28;1(1):18. doi: 10.1186/2049-2618-1-18.

18.

First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3.

Leung V, Loo VG, Frenette C, Domingo MC, Bourgault AM, Mulvey MR, Robson HG.

Can J Infect Dis Med Microbiol. 2012 Fall;23(3):117-20.

19.

Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.

René P, Frenette CP, Schiller I, Dendukuri N, Brassard P, Fenn S, Loo VG.

Diagn Microbiol Infect Dis. 2012 May;73(1):94-6. doi: 10.1016/j.diagmicrobio.2012.01.005. Epub 2012 Mar 15.

PMID:
22424900
20.

Host and pathogen factors for Clostridium difficile infection and colonization.

Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.

N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.

21.

Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile.

Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R, Haub K, Magrini V, Mardis ER, Gerding DN, Loo VG, Miller MA, Mulvey MR, Rupnik M, Dascal A, Dewar K.

J Clin Microbiol. 2011 Jun;49(6):2230-8. doi: 10.1128/JCM.00391-11. Epub 2011 Apr 20.

22.

Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease.

Manges AR, Labbe A, Loo VG, Atherton JK, Behr MA, Masson L, Tellis PA, Brousseau R.

J Infect Dis. 2010 Dec 15;202(12):1877-84. doi: 10.1086/657319. Epub 2010 Nov 4.

PMID:
21050115
23.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America.

Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.

PMID:
20307191
24.

Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile.

Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD.

Infect Control Hosp Epidemiol. 2009 Oct;30(10):939-44. doi: 10.1086/605322.

PMID:
19715426
25.

Antimicrobial-associated risk factors for Clostridium difficile infection.

Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA.

Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S19-31. doi: 10.1086/521859. Review.

PMID:
18177218
26.

A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.

Hubert B, Loo VG, Bourgault AM, Poirier L, Dascal A, Fortin E, Dionne M, Lorange M.

Clin Infect Dis. 2007 Jan 15;44(2):238-44. Epub 2006 Dec 6.

PMID:
17173224
27.

In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.

Bourgault AM, Lamothe F, Loo VG, Poirier L; CDAD-CSI Study Group.

Antimicrob Agents Chemother. 2006 Oct;50(10):3473-5.

28.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A.

N Engl J Med. 2005 Dec 8;353(23):2442-9. Epub 2005 Dec 1. Erratum in: N Engl J Med. 2006 May 18;354(20):2200.

29.

Clostridium difficile: a formidable foe.

Loo VG, Libman MD, Miller MA, Bourgault AM, Frenette CH, Kelly M, Michaud S, Nguyen T, Poirier L, Vibien A, Horn R, Laflamme PJ, René P.

CMAJ. 2004 Jul 6;171(1):47-8. No abstract available.

30.

Compliance with methicillin-resistant Staphylococcus aureus precautions in a teaching hospital.

Afif W, Huor P, Brassard P, Loo VG.

Am J Infect Control. 2002 Nov;30(7):430-3.

PMID:
12410221
31.

Lower respiratory tract infections in Inuit infants on Baffin Island.

Banerji A, Bell A, Mills EL, McDonald J, Subbarao K, Stark G, Eynon N, Loo VG.

CMAJ. 2001 Jun 26;164(13):1847-50.

32.

Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases.

Fallone CA, Barkun AN, Göttke MU, Best LM, Loo VG, Veldhuyzen van Zanten S, Nguyen T, Lowe A, Fainsilber T, Kouri K, Beech R.

Am J Gastroenterol. 2000 Mar;95(3):659-69.

PMID:
10710054
33.

Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature.

Soravia-Dunand VA, Loo VG, Salit IE.

Clin Infect Dis. 1999 Oct;29(4):862-8.

PMID:
10589904
34.

An outbreak of Serratia marcescens infections related to contaminated chlorhexidine.

Vigeant P, Loo VG, Bertrand C, Dixon C, Hollis R, Pfaller MA, McLean AP, Briedis DJ, Perl TM, Robson HG.

Infect Control Hosp Epidemiol. 1998 Oct;19(10):791-4.

PMID:
9801292
35.

Utility of serology in determining Helicobacter pylori eradication after therapy.

Fallone CA, Loo VG, Barkun AN.

Can J Gastroenterol. 1998 Mar;12(2):117-24.

PMID:
9559206
36.

In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.

Loo VG, Fallone CA, De Souza E, Lavallée J, Barkun AN.

J Antimicrob Chemother. 1997 Dec;40(6):881-3.

PMID:
9462442
37.

Hematoxylin and eosin staining of gastric tissue for the detection of Helicobacter pylori.

Fallone CA, Loo VG, Lough J, Barkun AN.

Helicobacter. 1997 Mar;2(1):32-5.

PMID:
9432319
38.

Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit.

Loo VG, Bertrand C, Dixon C, Vityé D, DeSalis B, McLean AP, Brox A, Robson HG.

Infect Control Hosp Epidemiol. 1996 Jun;17(6):360-4.

PMID:
8805066
39.
40.

The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones.

Loo VG, Lavellée J, McAlear D, Robson HG.

J Antimicrob Chemother. 1994 Mar;33(3):641-5. No abstract available.

PMID:
8040129
41.
42.

Isolation of Mycoplasma pneumoniae from pleural fluid.

Loo VG, Richardson S, Quinn P.

Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):443-5.

PMID:
1797459
43.

Survey of Neisseria gonorrhoeae antimicrobial susceptibility in Ontario.

Loo VG, Simor AE, Jaeger R, Low DE.

Can J Infect Dis. 1990 Winter;1(4):136-8.

44.

Survey of antimicrobial susceptibility in Neisseria gonorrhoeae in a non-STD population in Ontario.

Loo VG, Simor AE, Jaeger R, Low DE.

Can Dis Wkly Rep. 1989 Feb 18;15(7):33-4. English, French. No abstract available.

PMID:
2493995
45.

Role of iron in intracellular growth of Trypanosoma cruzi.

Loo VG, Lalonde RG.

Infect Immun. 1984 Sep;45(3):726-30.

Supplemental Content

Support Center